Tag Archives: patients

Dr. Michael Uro Foot Care, Sacramento has Treated Over 1000 Patients with Revolutionary Toenail Fungus Laser Treatment

Millions of people suffer from an embarrassing toenail fungus problem, known as onychomycosis, that can often be difficult to treat. There is now a treatment available that doesn’t require the use of expensive topical medications. Dr. Michael Uro Foot Care has successfully treated over thousands of patients with a non-invasive, drug-free toenail fungus laser treatment.

Sacramento, CA, May 24, 2012 (Straight Line PR) — Dr. Michael Uro Foot Care is pleased to announce the successful treatment of over a thousand patients with a revolutionary toenail fungus laser treatment. The doctor’s toenail fungus laser treatment is a non-invasive, drug-free procedure that vaporizes fungal spores embedded in the nail bed. Research indicates that this one-time procedure cures fungus in roughly 70 percent of patients.

Dr. Uro is the second podiatrist in the country to offer the toenail fungus laser treatment. Dr. Uro has treated more patients with this laser system than any other physician. He has trained doctors from across the United States in this exciting new technology, as well as England, Australia, Canada, Turkey and Guam.

“Many people suffer from toenail fungus, and it can be difficult to get rid of. The toenail fungus laser treatment kills the pathogens within the nail bed and addresses the root of the problem,” says Dr. Uro, doctor of podiatry at Dr. Michael Uro Foot Care ( http://www.toelaser.com ). “The toenail fungus laser treatment has given my patients the results they have been looking for.”

The laser is a specially designed, medical device that shines a laser light beam through the toenail, into the nail bed and nail plate. The laser literally vaporizes the embedded pathogens which cause toenail fungus. ( http://www.toelaser.com/laser-center ) The toenail fungus laser treatment does not harm the nail or surrounding skin. The procedure takes about 30 to 60 minutes and can be done comfortably in the privacy of a doctor’s office, with little or no discomfort.

Dr. Uro’s web site features several informative videos that describe the toenail fungus laser treatment process, at http://www.toelaser.com/laser-center/videos

“I really disliked the way my toenails looked due to a fungal infection, but didn’t want to treat my whole body with medication just to fix my toenails,” explained Susan, a patient at Dr. Michael Uro Footcare. “Dr. Uro’s toenail fungus laser treatment was the answer. I am very happy with the results. My follow-up treatments have gone very well and as soon as my toenails can grow a little more, I will feel very comfortable showing my feet in public. Thank you, Dr. Uro.”

To learn more about toenail fungus laser treatment visit Dr. Michael Uro Foot Care, Sacramento online at http://www.toelaser.com

About Dr. Michael Uro Footcare:
Dr. Michael A. Uro has been a Doctor of Podiatric Medicine in the Sacramento area for over 30 years. His clinic specializes in the treatment of toenail fungus and foot and ankle problems. He has served as Podiatry Chair of the surgery departments of both Mercy General Hospital and Sutter General Hospital, where he continues to have surgical privileges. He also continues to serve on multiple medical boards such as President of the Sacramento Valley Podiatric Medical Society, and is a member of the California Podiatric Medical Association. He has also been an off-site clinician in the training of University of California at Davis family practice physicians. Contact Dr. Michael Uro Foot Care at (916) 920-9292 or online at http://www.toelaser.com/contact-us

Press Contact:
Half a Bubble Out Media
680 Rio Lindo Ave.
Chico, CA 95926
(530) 345-8295
habomedia@gmail.com
www.halfabubbleout.com

Please contact http://www.PressReleaseNation.com for corrections or updates.

Contact:
David Lockman
RichContent
9734 Lincoln Lane
Blaine, WA 98230
360.312.4312
dlock@richcontent.tv
http://www.RichContent.com

IAPAM hCG Protocol Remediates Rising Healthcare Costs

Over 21,000 patients have successfully lost weight using the IAPAM’s Exclusive hCG Protocol, and a new study from Cornell University reports that rising healthcare costs can be positively impacted through offering patients safe and sustained weight loss programs.

Las Vegas, Nevada (April 18, 2012) — The IAPAM offers the most comprehensive hCG Training for physicians looking to add hCG for weight loss to their practices. Over 21,000 patients have successfully lost weight using the IAPAM’s Exclusive hCG Protocol, and a new study from Cornell University reports that rising healthcare costs can be positively impacted through offering patients safe and sustained weight loss programs.

A recent study from Cornell University found that, “obesity now accounts for almost 21 % of U.S. health care costs – more than twice the previous estimates.” The study also reports that “an obese person incurs medical costs that are $2,741 higher than if they were not obese. Nationwide, that translates into $190.2 billion per year, or 20.6 % of national health expenditures. Previous estimates had pegged the cost of obesity at $85.7 billion, or 9.1 % of national health expenditures.” Moreover, a similar study in March 2012 from the Journal of Occupational and Environmental Medicine, reported that, “obesity [now] adds more to health care costs than smoking does.”

In an effort to support physicians as they offer safe and effective weight management programs to their patients, the IAPAM (http://www.iapam.com) has developed a tool to bring trained hCG physicians and patients together: the IAPAM’s hCG Diet Clinic Directory (http://www.iapam.com/aesthetic-resources/hcg-diet-clinics). The IAPAM’s hCG Clinic Listing offers the most comprehensive hCG Diet Clinic listing of physicians, all of whom have been expertly trained in hCG for weight loss, by the IAPAM.

Patients seeking physicians, who have completed the IAPAM’s hCG Training, can browse the directory to find an hCG expert physician in their area. All physicians listed on the IAPAM hCG Diet Clinic Directory page have:

1. advanced training in utilizing hCG for weight loss,
2. only offer pharmaceutical grade hCG, and
3. all their hCG patients use the IAPAM’s comprehensive hCG Protocol Patient Guidebook.

Jeff Russell, Executive Director of the IAPAM, and a member of the expert faculty of instructors at the IAPAM’s hCG Physician Weight Loss Training, comments that, “since being showcased on the Dr. Oz Show in February 2011 and March 2012, patient demand for medically supervised hCG weight loss has exploded. We are seeing a correlating increase in physician-demand for the IAPAM’s hCG training, to capture this growing market.” To date, “well over 21,000 patients have successfully lost weight on hCG using the IAPAM’s Exclusive hCG Protocol (http://www.hcgtraining.com), based on Dr. Simeons manuscript, Pounds and Inches, and the IAPAM’s hCG training is taught by a faculty who operate hCG weight loss clinics, allowing physicians and their staff to learn from the faculty’s vast experience,” shares Russell.

IAPAM’s hCG Training is Complete and Comprehensive

Physicians who have attended the IAPAM’s full day hCG training are the best trained hCG physicians in North America. In fact, the IAPAM’s hCG Training is the only medical weight loss training approved for a special medical malpractice rate for those who have attended and have been certified by the IAPAM.

For physicians interested in adding hCG for Weight Loss, please note that all of the IAPAM’s hCG Medical Weight Management seminars in 2010-2012 have sold out. To register for the next session in 2012, please visit: http://www.hcgtraining.com or contact the IAPAM at 1-800-219-5108 ext 708.

About the IAPAM: The International Association for Physicians in Aesthetic Medicine

The International Association for Physicians in Aesthetic Medicine is a voluntary global association of physicians and supporters, which sets standards for the aesthetic medical profession worldwide. The goal of the association is to offer education, ethical standards, credentialing, and member benefits to members around the globe. IAPAM membership is open to all licensed medical doctors (MDs), doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox ® training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 ext. 708

Websites:
http://www.AestheticMedicineSymposium.com

1,800 Sign Up for IAPAM hCG Weight Loss Programs in March 2012

The IAPAM reports that over 1,800 Patients began losing weight using the IAPAM’s hCG Protocol in March.

Las Vegas, Nevada, April 4, 2012 — More patients began their weight loss journey using the IAPAM’s Exclusive IAPAM hCG Protocol in March 2012, than in any month before. The IAPAM reports that over 1,800 Patients began losing weight using the IAPAM’s hCG Protocol in March. To date, over 21,000 patients have lost weight using the IAPAM’s hCG Weight Loss Protocol and over 450 physicians have attended the IAPAM hCG Training and are adding this cash based modality to their practices.

On March 24, 2012, the Dr. Oz Show again showcased hCG for weight loss. Since that show aired, patient demand for the hCG diet has exploded, with patients flocking to physicians who offer hCG for weight loss. In March alone, the IAPAM reports that 1800 patients began losing weight using the IAPAM’s updated hCG weight loss protocols (http://www.hcgtraining.com).

Physicians can safely offer hCG for weight loss to their patients after completing the IAPAM’s comprehensive Medically Supervised Weight Loss Program featuring hCG. The IAPAM’s hCG Training is the leading physician directed hCG weight loss program in the world. The IAPAM (http://www.iapam.com) has trained over 450 physicians on how to effectively offer hCG (human Chorionic Gonadotropin) to their patients, and well over 21,000 patients have successfully lost weight on hCG using the IAPAM’s Exclusive hCG Protocol (http://www.hcgtraining.com), based on Dr. Simeons manuscript, Pounds and Inches. The IAPAM’s hCG training is taught by a faculty who operate hCG weight loss clinics, allowing physicians and their staff to learn from the faculty’s vast experience.

The IAPAM’s hCG Training includes:

1. Detailed IAPAM hCG Program Protocols
2. hCG Program Guidebook to offer patients (hCG friendly recipes, food journal, tips)
3. Common medical hCG contraindications
4. Consent forms, medical history forms
5. Patient selection criteria
6. Patient PowerPoint presentations for the waiting room
7. Phone scripts & call logs for your staff
8. hCG ordering information and special pricing
9. Legal/Insurance considerations, current FDA status
10. VLCD/LCD diet programs
11. Meal replacement diet programs
12. Ketogenic based diet programs
13. Utilizing B6/B12 injections in weight loss
14. Using prescription appetite suppressants in weight loss
15. Metabolism testing as a profit center
16. Laser assisted lipolysis
17. Special hCG Facebook discussion forum and much much more.

Jeff Russell, Executive Director of the IAPAM, and a member of the expert faculty of instructors at the IAPAM’s hCG Physician Weight Loss Training, comments that, “as medically supervised hCG weight loss programs are being requested by patients, we are seeing a correlating increase in physician-demand for the IAPAM’s hCG training.” Mr. Russell also emphasizes that, “through the comprehensive education, and the year of practice support offered by the IAPAM, doctors can appreciate the effects of medications, the implications of plateauing, the importance of vitamin supplements, engage in ongoing dialogue with each other and hCG experts, and understand all the other nuances of the IAPAM protocol that result in patient satisfaction and enduring weight loss.”

To register for the next IAPAM hCG Weight Loss Training session, go to http://www.hcgtraining.com or contact the IAPAM at 1-800-219-5108 ext. 708 or email info@theiapam.com

About the IAPAM: The International Association for Physicians in Aesthetic Medicine

The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs), dentists (DDSs/DMDs) doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox ® training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x708
info@theiapam.com

Websites:
http://www.AestheticMedicineSymposium.com

Trials Show Promise of Human Virus to Treat Head and Neck Cancer Patients

Cancers shrank for about one third of the patients who could be evaluated, and disease stabilised for a further third. For one patient, all signs of their cancer disappeared.

Leeds, UK – April 3, 2012 — A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research.

RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech Inc with preclinical and clinical studies conducted at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital. It is based on a virus (reovirus type 3 Dearing) that is found in almost all adults’ respiratory and gastrointestinal tracts without causing any symptoms.

RT3D has the ability to grow in and kill certain types of cancer cells, but does not grow in normal cells.

Previous trials injecting patients with the virus on its own showed limited effectiveness, but the team found that RT3D appeared to magnify the effects of platin and taxane-based chemotherapy on tumour cells.

Dr Kevin Harrington and colleagues in Leeds therefore started a clinical trial testing intravenous RT3D in combination with chemotherapeutics carboplatin and paclitaxel in 31 patients with advanced cancers who had stopped responding to standard treatments.

An initial Phase I study was carried out in patients with a range of advanced cancers, which showed the drug combination was safe. Side-effects were found to be generally mild, and consistent with chemotherapy alone.

Patients with head and neck cancers were found to have the best responses, so a Phase II expansion study at The Royal Marsden Hospital, London, and St James’s Hospital, Leeds, was therefore targeted to patients with these types of cancers.

Cancers shrank for about one third of the patients who could be evaluated, and disease stabilised for a further third. For one patient, all signs of their cancer disappeared.

“We saw really very impressive response rates in these patients. These are patients whose cancers had grown despite a great deal of previous treatment, including platinum-based chemotherapy for many,” Dr Harrington, Leader of the ICR’s Targeted Therapy Team and Consultant Oncologist at The Royal Marsden, said. “Under those circumstances, we’d expect that the average response rate to chemotherapy alone might be as low as single digits figures and the average survival would be somewhere between three to four months. In our Phase I/II study we show this had been prolonged to an average of seven months, albeit not in a randomised trial.”

“Based on the results of this study we’ve now started recruiting patients with advanced head and neck cancer to a randomised Phase III trial, in which all patients will receive chemotherapy and half will receive Reolysin as well. We are extremely excited about this progress.”

The study also found the virus was not shed after treatment. This means people could be given the drug as outpatients as no risk was found that they could transmit the virus to others.

Head and neck cancers include tumours of the eye, nasal cavity, tongue, gums, lip, cheeks, voice box and oesophagus. Around 650,000 people are diagnosed with squamous cell cancer of the head and neck each year worldwide, and around 350,000 die from the disease annually.

Notes to Editors:

Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies with first author Eleni M. Karapanagiotou from the ICR and The Royal Marsden publishes in the print edition of Clinical Cancer Research on April 1.

The Phase III trial is recruiting patients with head and neck cancer who have already been treated with platinum but not taxane. More details at: http://clinicaltrials.gov/ct2/show/NCT01166542

The Institute of Cancer Research (ICR) is one of the world’s most influential cancer research institutes.

Scientists and clinicians at the ICR are working every day to make a real impact on cancer patients’ lives. Through its unique partnership with The Royal Marsden Hospital and ‘bench-to-bedside’ approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four cancer centres globally.

The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

As a college of the University of London, the ICR provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public.

The ICR’s mission is to make the discoveries that defeat cancer. For more information visit http://www.icr.ac.uk

The Royal Marsden NHS Foundation Trust

The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.

Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehensive cancer centre in Europe treating over 44,000 patients every year. It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies. The Royal Marsden also provides community services in the London boroughs of Sutton and Merton and in June 2010, along with the ICR, the Trust launched a new academic partnership with Mount Vernon Cancer Centre in Middlesex.

Since 2004, the hospital’s charity, The Royal Marsden Cancer Charity, has helped raise over £50 million to build theatres, diagnostic centres, and drug development units. Prince William became President of The Royal Marsden in 2007, following a long royal connection with the hospital.

Media Contacts:
Jane Bunce on 0207 153 5106 or after hours 077217 47900
Tatjana Trpoksa on 0207 153 5312 or after hours 07780689891

Media Contact (US) for Oncolytics: Janet Vasquez / 212-825-3210

Social Medicine Is Understanding Patients By Launching New Website

Social Medicine, a health based social networking site, helps people suffering from a variety of health conditions, to globally connect, help and share information with others in similar situations.

Melbourne, Australia, Monday – March 19, 2012 — Social Medicine ( http://www.social-medicine.org ) opens the doors for patients that were not previously made available. Patients now have the opportunity for:
* Instant two way communication to help bring patients closer
* Supportive communities through enhanced functionality
* Friend circles to allow patients to connect and bond with others globally

Social Medicine (Social-medicine.org), a health based social networking site, helps people suffering from a variety of health conditions, to globally connect, help and share information with others in similar situations, by focusing on bridging the gap of patient-to-patient communication, and patient-to-practitioner communication, with all the social networking features and functionality expected in today’s society.

Community Support:
Social Medicine fosters community support, where real people in similar situations come together, to circumvent negative feelings like disconnection and loneliness, and focus on improving self-esteem, understanding, communication, relationships, and peer support.

“As a psoriasis sufferer, I know first hand how hard it can be to deal with an illness, without that all essential support from people who truly understand. After spending years managing my condition alone, I turned to the Internet for help. I found a sheer number of forums, blogs, and communities, in which psoriasis was discussed, but I didn’t find it to be a personal experience,” says Michael Dornan, the creator of Social Medicine.

Social Medicine’s online health communities does not show any geographical boundaries; anonymity from stigmatizing, embarrassing, and sensitive issues; increasing self-disclosure; and encouraging honesty. Even people with rare diseases can find peers online. The anonymity of online communities may facilitate the participation of certain people, who may be culturally and socially conditioned not to ask for help and support.

Understanding Patient’s Difficulties:
Why are patients turning to the web for information? There are increasing demands of consumer driven health content. It is seen that 48% of people with cancer reported that they had insufficient information provided by their physicians, while 20% were not satisfied with the information given and 39% of women with breast cancer indicated that they wished that they had help with knowing what questions to ask. (Gunther Eysenbach MD, MPH, The Impact Of Internet On Cancer Outcomes, American Cancer Society, 2003). However, dissatisfaction with information provided is not the only reason why patients turn to the Internet.

Social Medicine aims to better understand how people are connecting and sharing information about their medical conditions, the various treatments and products they are using. As communication on medical conditions is already undertaken in forums to some extent, these forums are now falling behind in functionality that would significantly improve patient’s experiences if communication was shared on social networking platforms.

There is a great need for more information. Patients want to know what other patients have done, used or experienced with their condition. The provision of information provided to patients has been shown to help them gain control, reduce anxiety, create realistic expectations, promote self-care and participation, and generate feelings of safety and security. The satisfaction with information provided has been shown to correlate with quality of life. People, who feel satisfied with the adequacy of information given, are more likely to feel happy with their level of participation and in the overall process of decision-making.

Psoriasis Social, the initial platform that paved the way for Social Medicine, demonstrated that patients understood what a social network for their condition offered over forums and other sites. “Psoriasis Social took off with a speed that surprised me. In a short period of time approximately 400 people globally, registered and became friends. My simple goal was to give psoriasis sufferers a voice, a sounding board, and a close-knit and supportive community for people who understood, what it was like to live with the condition. Soon Social Medicine was born, a platform for those who suffer from a range of illnesses and conditions, now have a community driven support network, and an avenue for organisations who may like to reach out to people via this platform or support its development,” says Michael Dornan, founder of Social Medicine.

Visit http://www.pr.com/press-release/397614 to read the complete press release.

Press & Media Contact:
Michael Dornan
Social-Medicine.org
Melbourne, Australia
61431174896
michael.dornan@social-medicine.org
http://www.social-medicine.org